Literature DB >> 28194039

Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation.

S Kobayashi1, A Kobayashi1, Y Osawa1, S Nagao1, K Takano1, Y Okada1, N Tachi1, M Teramoto1, T Kawamura1, T Horiuchi1, S Kato1, T Maekawa1, T Yamamura1, J Watanabe1, Y Harada2, H Harada2, K Sato1, F Kimura1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28194039     DOI: 10.1038/leu.2017.44

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

1.  Clonal history of a cord blood donor cell leukemia with prenatal somatic JAK2 V617F mutation.

Authors:  P Hirsch; A C Mamez; R Belhocine; S Lapusan; R Tang; L Suner; D Bories; C Marzac; F Fava; O Legrand; M Mohty; L Douay; F Delhommeau
Journal:  Leukemia       Date:  2016-03-01       Impact factor: 11.528

2.  Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation.

Authors:  G Berger; E van den Berg; B Sikkema-Raddatz; K M Abbott; R J Sinke; L B Bungener; A B Mulder; E Vellenga
Journal:  Leukemia       Date:  2016-10-31       Impact factor: 11.528

Review 3.  Donor cell leukemia: a review.

Authors:  Daniel H Wiseman
Journal:  Biol Blood Marrow Transplant       Date:  2010-10-15       Impact factor: 5.742

4.  Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms.

Authors:  Chantana Polprasert; Isabell Schulze; Mikkael A Sekeres; Hideki Makishima; Bartlomiej Przychodzen; Naoko Hosono; Jarnail Singh; Richard A Padgett; Xiaorong Gu; James G Phillips; Michael Clemente; Yvonne Parker; Daniel Lindner; Brittney Dienes; Eckhard Jankowsky; Yogen Saunthararajah; Yang Du; Kevin Oakley; Nhu Nguyen; Sudipto Mukherjee; Caroline Pabst; Lucy A Godley; Jane E Churpek; Daniel A Pollyea; Utz Krug; Wolfgang E Berdel; Hans-Ulrich Klein; Martin Dugas; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Kenichi Yoshida; Seishi Ogawa; Carsten Müller-Tidow; Jaroslaw P Maciejewski
Journal:  Cancer Cell       Date:  2015-04-23       Impact factor: 31.743

Review 5.  Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer.

Authors:  Peter D Adams; Heinrich Jasper; K Lenhard Rudolph
Journal:  Cell Stem Cell       Date:  2015-06-04       Impact factor: 24.633

Review 6.  Myelodysplasia is in the niche: novel concepts and emerging therapies.

Authors:  E Bulycheva; M Rauner; H Medyouf; I Theurl; M Bornhäuser; L C Hofbauer; U Platzbecker
Journal:  Leukemia       Date:  2014-11-14       Impact factor: 11.528

7.  The interplay between DNA damage response and RNA processing: the unexpected role of splicing factors as gatekeepers of genome stability.

Authors:  Chiara Naro; Pamela Bielli; Vittoria Pagliarini; Claudio Sette
Journal:  Front Genet       Date:  2015-04-15       Impact factor: 4.599

8.  A tale of two siblings: two cases of AML arising from a single pre-leukemic DNMT3A mutant clone.

Authors:  C N Hahn; D M Ross; J Feng; A Beligaswatte; D K Hiwase; W T Parker; M Ho; M Zawitkowski; K L Ambler; G D Cheetham; Y K Lee; M Babic; C M Butcher; G A Engler; A L Brown; R J D'Andrea; I D Lewis; A W Schreiber; L B To; H S Scott
Journal:  Leukemia       Date:  2015-03-09       Impact factor: 11.528

9.  Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation.

Authors:  Lukasz P Gondek; Gang Zheng; Richard Jones; Christopher D Gocke; Gabriel Ghiaur; Amy E DeZern; William Matsui; Srinivasan Yegnasubramanian; Ming-Tseh Lin; Mark Levis; James R Eshleman; Ravi Varadhan; Noah Tucker
Journal:  Leukemia       Date:  2016-03-15       Impact factor: 11.528

  9 in total
  21 in total

Review 1.  DDX41-related myeloid neoplasia.

Authors:  Jaroslaw P Maciejewski; Richard A Padgett; Anna L Brown; Carsten Müller-Tidow
Journal:  Semin Hematol       Date:  2017-04-21       Impact factor: 3.851

2.  Donor-derived MDS/AML in families with germline GATA2 mutation.

Authors:  Pallavi Galera; Amy P Hsu; Weixin Wang; Stephenie Droll; Rui Chen; Jason R Schwartz; Jeffery M Klco; Sally Arai; Luke Maese; Christa Zerbe; Mark J Parta; Neal S Young; Steven M Holland; Dennis D Hickstein; Katherine R Calvo
Journal:  Blood       Date:  2018-09-19       Impact factor: 22.113

Review 3.  Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome.

Authors:  Lacey Williams; Kimberley Doucette; Judith E Karp; Catherine Lai
Journal:  Bone Marrow Transplant       Date:  2021-03-08       Impact factor: 5.483

Review 4.  Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).

Authors:  Anna L Brown; Christopher N Hahn; Hamish S Scott
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

Review 5.  Myeloid neoplasms with germline DDX41 mutation.

Authors:  Jesse J C Cheah; Christopher N Hahn; Devendra K Hiwase; Hamish S Scott; Anna L Brown
Journal:  Int J Hematol       Date:  2017-05-25       Impact factor: 2.490

Review 6.  Germline and Somatic Defects in DDX41 and its Impact on Myeloid Neoplasms.

Authors:  Talha Badar; Timothy Chlon
Journal:  Curr Hematol Malig Rep       Date:  2022-07-04       Impact factor: 4.213

7.  Novel DDX41 variants in Thai patients with myeloid neoplasms.

Authors:  Chantana Polprasert; June Takeda; Pimjai Niparuck; Thanawat Rattanathammethee; Arunrat Pirunsarn; Amornchai Suksusut; Sirorat Kobbuaklee; Kitsada Wudhikarn; Panisinee Lawasut; Sunisa Kongkiatkamon; Suporn Chuncharunee; Kritanan Songserm; Prasit Phowthongkum; Udomsak Bunworasate; Yasuhito Nannya; Kenichi Yoshida; Hideki Makishima; Seishi Ogawa; Ponlapat Rojnuckarin
Journal:  Int J Hematol       Date:  2019-11-11       Impact factor: 2.490

Review 8.  Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice.

Authors:  Kristen E Schratz; Amy E DeZern
Journal:  Hematol Oncol Clin North Am       Date:  2020-01-06       Impact factor: 3.722

Review 9.  Advances in germline predisposition to acute leukaemias and myeloid neoplasms.

Authors:  Jeffery M Klco; Charles G Mullighan
Journal:  Nat Rev Cancer       Date:  2020-12-16       Impact factor: 60.716

10.  Stem cell donors should be screened for CHIP.

Authors:  Amy E DeZern; Lukasz P Gondek
Journal:  Blood Adv       Date:  2020-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.